These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38655818)

  • 1. SARS-CoV-2 infection induces thymic atrophy mediated by IFN-γ in hACE2 transgenic mice.
    Rizvi ZA; Sadhu S; Dandotiya J; Sharma P; Binayke A; Singh V; Das V; Khatri R; Kumar R; Samal S; Kalia M; Awasthi A
    Eur J Immunol; 2024 Jul; 54(7):e2350624. PubMed ID: 38655818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ.
    Liu B; Zhang X; Deng W; Liu J; Li H; Wen M; Bao L; Qu J; Liu Y; Li F; An Y; Qin C; Cao B; Wang C
    Cell Death Dis; 2014 Oct; 5(10):e1440. PubMed ID: 25275588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chagasic thymic atrophy does not affect negative selection but results in the export of activated CD4+CD8+ T cells in severe forms of human disease.
    Morrot A; Terra-Granado E; Pérez AR; Silva-Barbosa SD; Milićević NM; Farias-de-Oliveira DA; Berbert LR; De Meis J; Takiya CM; Beloscar J; Wang X; Kont V; Peterson P; Bottasso O; Savino W
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1268. PubMed ID: 21858238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Outcomes of Infection by Wild-Type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 Variants of Concern in K18-hACE2 Transgenic Mice.
    He Y; Henley J; Sell P; Comai L
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
    Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
    Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way.
    Cao Z; Wang J; Liu X; Liu Y; Li F; Liu M; Chiu S; Jin X
    mBio; 2024 Jun; 15(6):e0090524. PubMed ID: 38727220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
    Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
    PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of thymic atrophy and loss of thymic output by type-I interferons during chronic viral infection.
    Démoulins T; Baron ML; Gauchat D; Kettaf N; Reed SJ; Charpentier T; Kalinke U; Lamarre A; Ahmed R; Sékaly RP; Sarkar S; Kalia V
    Virology; 2022 Feb; 567():77-86. PubMed ID: 35032866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A virus-induced thymus atrophy differentially affects dynamics of conventional and regulatory T-cell development in mice.
    Elfaki Y; Robert PA; Binz C; Falk CS; Bruder D; Prinz I; Floess S; Meyer-Hermann M; Huehn J
    Eur J Immunol; 2021 May; 51(5):1166-1181. PubMed ID: 33638148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2.
    Hassert M; Geerling E; Stone ET; Steffen TL; Feldman MS; Dickson AL; Class J; Richner JM; Brien JD; Pinto AK
    PLoS Pathog; 2020 Dec; 16(12):e1009163. PubMed ID: 33326500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection.
    Drelich AK; Rayavara K; Hsu J; Saenkham-Huntsinger P; Judy BM; Tat V; Ksiazek TG; Peng BH; Tseng CK
    PLoS Pathog; 2024 Jun; 20(6):e1011777. PubMed ID: 38913740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.